194 related articles for article (PubMed ID: 15669885)
1. Sertraline treatment of pathological gambling: a pilot study.
Saiz-Ruiz J; Blanco C; Ibáñez A; Masramon X; Gómez MM; Madrigal M; Díez T
J Clin Psychiatry; 2005 Jan; 66(1):28-33. PubMed ID: 15669885
[TBL] [Abstract][Full Text] [Related]
2. A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling.
Kim SW; Grant JE; Adson DE; Shin YC; Zaninelli R
J Clin Psychiatry; 2002 Jun; 63(6):501-7. PubMed ID: 12088161
[TBL] [Abstract][Full Text] [Related]
3. A pilot placebo-controlled study of fluvoxamine for pathological gambling.
Blanco C; Petkova E; Ibáñez A; Sáiz-Ruiz J
Ann Clin Psychiatry; 2002 Mar; 14(1):9-15. PubMed ID: 12046642
[TBL] [Abstract][Full Text] [Related]
4. Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depression.
Ravindran AV; Guelfi JD; Lane RM; Cassano GB
J Clin Psychiatry; 2000 Nov; 61(11):821-7. PubMed ID: 11105734
[TBL] [Abstract][Full Text] [Related]
5. Nefazodone treatment of pathological gambling: a prospective open-label controlled trial.
Pallanti S; Baldini Rossi N; Sood E; Hollander E
J Clin Psychiatry; 2002 Nov; 63(11):1034-9. PubMed ID: 12444818
[TBL] [Abstract][Full Text] [Related]
6. Sertraline treatment of panic disorder: response in patients at risk for poor outcome.
Pollack MH; Rapaport MH; Clary CM; Mardekian J; Wolkow R
J Clin Psychiatry; 2000 Dec; 61(12):922-7. PubMed ID: 11206597
[TBL] [Abstract][Full Text] [Related]
7. Olanzapine in the treatment of pathological gambling: a negative randomized placebo-controlled trial.
McElroy SL; Nelson EB; Welge JA; Kaehler L; Keck PE
J Clin Psychiatry; 2008 Mar; 69(3):433-40. PubMed ID: 18251624
[TBL] [Abstract][Full Text] [Related]
8. Escitalopram treatment of pathological gambling with co-occurring anxiety: an open-label pilot study with double-blind discontinuation.
Grant JE; Potenza MN
Int Clin Psychopharmacol; 2006 Jul; 21(4):203-9. PubMed ID: 16687991
[TBL] [Abstract][Full Text] [Related]
9. Short-term single-blind fluvoxamine treatment of pathological gambling.
Hollander E; DeCaria CM; Mari E; Wong CM; Mosovich S; Grossman R; Begaz T
Am J Psychiatry; 1998 Dec; 155(12):1781-3. PubMed ID: 9842795
[TBL] [Abstract][Full Text] [Related]
10. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder.
Davidson JR; Rothbaum BO; van der Kolk BA; Sikes CR; Farfel GM
Arch Gen Psychiatry; 2001 May; 58(5):485-92. PubMed ID: 11343529
[TBL] [Abstract][Full Text] [Related]
11. High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial.
Ninan PT; Koran LM; Kiev A; Davidson JR; Rasmussen SA; Zajecka JM; Robinson DG; Crits-Christoph P; Mandel FS; Austin C
J Clin Psychiatry; 2006 Jan; 67(1):15-22. PubMed ID: 16426083
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind, placebo-controlled trial on the efficacy and tolerability of sertraline in Iranian veterans with post-traumatic stress disorder.
Panahi Y; Moghaddam BR; Sahebkar A; Nazari MA; Beiraghdar F; Karami G; Saadat AR
Psychol Med; 2011 Oct; 41(10):2159-66. PubMed ID: 21349225
[TBL] [Abstract][Full Text] [Related]
13. Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study.
Van Ameringen MA; Lane RM; Walker JR; Bowen RC; Chokka PR; Goldner EM; Johnston DG; Lavallee YJ; Nandy S; Pecknold JC; Hadrava V; Swinson RP
Am J Psychiatry; 2001 Feb; 158(2):275-81. PubMed ID: 11156811
[TBL] [Abstract][Full Text] [Related]
14. An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression.
Schneider LS; Nelson JC; Clary CM; Newhouse P; Krishnan KR; Shiovitz T; Weihs K;
Am J Psychiatry; 2003 Jul; 160(7):1277-85. PubMed ID: 12832242
[TBL] [Abstract][Full Text] [Related]
15. Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?
Hollander E; Pallanti S; Allen A; Sood E; Baldini Rossi N
Am J Psychiatry; 2005 Jan; 162(1):137-45. PubMed ID: 15625212
[TBL] [Abstract][Full Text] [Related]
16. Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling.
Grant JE; Potenza MN; Hollander E; Cunningham-Williams R; Nurminen T; Smits G; Kallio A
Am J Psychiatry; 2006 Feb; 163(2):303-12. PubMed ID: 16449486
[TBL] [Abstract][Full Text] [Related]
17. A placebo-controlled, randomized withdrawal study of sertraline for panic disorder in Japan.
Kamijima K; Kuboki T; Kumano H; Burt T; Cohen G; Arano I; Hamasaki T
Int Clin Psychopharmacol; 2005 Sep; 20(5):265-73. PubMed ID: 16096517
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of sertraline in a 12-week trial for generalized anxiety disorder.
Allgulander C; Dahl AA; Austin C; Morris PL; Sogaard JA; Fayyad R; Kutcher SP; Clary CM
Am J Psychiatry; 2004 Sep; 161(9):1642-9. PubMed ID: 15337655
[TBL] [Abstract][Full Text] [Related]
19. A randomized, placebo-controlled trial of sertraline in the treatment of night eating syndrome.
O'Reardon JP; Allison KC; Martino NS; Lundgren JD; Heo M; Stunkard AJ
Am J Psychiatry; 2006 May; 163(5):893-8. PubMed ID: 16648332
[TBL] [Abstract][Full Text] [Related]
20. Sertraline treatment of posttraumatic stress disorder: results of 24 weeks of open-label continuation treatment.
Londborg PD; Hegel MT; Goldstein S; Goldstein D; Himmelhoch JM; Maddock R; Patterson WM; Rausch J; Farfel GM
J Clin Psychiatry; 2001 May; 62(5):325-31. PubMed ID: 11411812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]